A question kit for finding care
Bring a question. Expect a clear answer.
The old studies offer some clues. They do not give a complete answer for an adult considering a pharmacy-made product now.
The older sermorelin studies most often reported a brief flushed face and soreness where the injection went in.
These findings came largely from children’s research in the 1990s, not long-term studies of current pharmacy-made products in adults.
As of September 28, 2026, no current Food and Drug Administration (FDA) sermorelin label provides rates for side effects.
A question to take with you
What harms are known for this plan, and which parts are still uncertain?
As of September 28, 2026, sermorelin has no current FDA-reviewed guidance on pregnancy or a current label listing who must avoid it.
A missing label is not evidence that the medicine has no harms.
Bring pregnancy, breastfeeding, other medicines, and your health history into the conversation. Ask how each affects the clinician’s recommendation.
Evidence to keep in view
In reviews of related peptides, the FDA raised possible concerns tied to higher growth hormone, including blood sugar changes, fluid build-up, and tumor risk.
The FDA wrote about related drugs; this does not establish that sermorelin causes cancer or supply rates of harm for sermorelin.
The FDA says poor compounding can leave a product dirty or with the wrong amount of the drug ingredient.
That is a reason to ask who makes it and how the pharmacy handles product questions.
Ask for written instructions from the prescriber and pharmacy about the exact product, including storage and what to do if something seems wrong.
Check the maker’s public record →A severe allergic reaction can endanger life, with breathing difficulty or swelling affecting the face or tongue among its possible signs.
For symptoms of a severe allergic reaction, MedlinePlus advises calling 911 or seeking care at the closest emergency room.
Read the MedlinePlus emergency guidance →For a medicine problem, patients can also file a report through MedWatch, the FDA reporting program.
Find the FDA MedWatch reporting service →